Fibrinolysis, the breakdown of fibrin polymer, occurs by at least two pathways resulting in the active agents protein C and plasmin. The latter is the better characterised and the term fibrinolysis is commonly taken to mean the plasmin pathway; protein C is discussed in the submenu.
Drugs which affect plasmin production are clinically important: accelerating agents include streptokinase; retarding agents include tranexamic acid.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.